4.5 Article

The incidence of acute urinary retention secondary to BPH is increasing among California men

Journal

PROSTATE CANCER AND PROSTATIC DISEASES
Volume 16, Issue 3, Pages 260-265

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/pcan.2013.11

Keywords

urinary retention; BPH; incidence; lower urinary tract symptoms; alpha-blocker; five alpha-reductase inhibitor

Ask authors/readers for more resources

BACKGROUND: Current epidemiological patterns of adverse events of clinical BPH remain unclear. We investigated trends in acute urinary retention (AUR) associated with BPH in a large, population-based cohort. METHODS: We utilized the California Office of Statewide Health Planning and Development Database to examine 3 724 016 emergency room (ER) visits in California among men aged >= 50 years from 2007 to 2010. Outcomes included AUR for which BPH was the primary diagnosis, AUR for which BPH was a secondary diagnosis and urethral catheterization for AUR. We generated adjusted odds ratios (ORadj) using multivariate logistic regression to determine longitudinal trends. RESULTS: A total of 17 023 men presented with a diagnosis of BPH-associated AUR, the unadjusted incidence of which increased from 4.00 per 1000 ER visits in 2007 to 5.23 per 1000 ER visits in 2010 (P<0.001). In adjusted analyses, primary AUR (ORadj = 1.25; 95% confidence interval (CI), 1.19-1.32; P<0.001) and secondary AUR (ORadj = 1.80; 95% CI, 1.62-2.00; P<0.001) increased 25% and 80%, respectively. Urethral catheterization for primary (ORadj = 1.30; 95% CI, 1.22-1.39; P<0.001) and secondary (ORadj = 1.82; 95% CI, 1.57-2.11; P<0.001) AUR increased 30% and 82%, respectively. Asian race (P<0.001), Hispanic race (P<0.001) and commercial insurance (P<0.001) were associated with significantly increased risks of AUR and urethral catheterization. CONCLUSIONS: Between 2007 and 2010, the observed incidence of BPH-associated AUR increased substantially in a large and ethnically diverse male population of the United States.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available